Financial Gravity Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$867 Hold
10
﹤0.01% 769
2025
Q4
$961 Hold
10
﹤0.01% 630
2025
Q3
$952 Buy
+10
New +$919 ﹤0.01% 809
2025
Q1
$899 Buy
+10
New +$895 ﹤0.01% 885
2024
Q2
$787 Sell
10
-107
-91% -$8.77K ﹤0.01% 848
2024
Q1
$10.2K Sell
117
-1
-0.8% -$85 ﹤0.01% 472
2023
Q4
$9.85K Buy
+118
New +$8.99K ﹤0.01% 490
2021
Q3
$125K Buy
+1
New +$129 0.06% 290
2021
Q2
Hold
0
294
2019
Q4
$0 Sell
1
-131
-99% -$14.4K ﹤0.01% 1588
2019
Q3
$14K Sell
132
-109
-45% -$11.4K 0.01% 534
2019
Q2
$24K Buy
241
+100
+71% +$9.13K 0.02% 454
2019
Q1
$13K Buy
+141
New +$12.6K 0.01% 512
2018
Q3
$15K Buy
171
+33
+24% +$3.05K 0.02% 511
2018
Q2
$12K Sell
138
-8
-5% -$668 0.01% 536
2018
Q1
$12K Buy
+146
New +$12K 0.01% 565

Other funds holding MDT

Financial Gravity Asset Management's MDT Position: Q1 2026 in Review

Financial Gravity Asset Management held its Medtronic (MDT) position steady in Q1 2026 at 10 shares worth $867. The position accounts for ﹤0.01% of the portfolio, ranked #769.

Financial Gravity Asset Management first reported a position in MDT in Q1 2018 and has held it in 15 quarters since. The position peaked at $125K in Q3 2021. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Financial Gravity Asset Management held 10 shares of Medtronic worth $867 as of Q1 2026.
  • Financial Gravity Asset Management left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #769 holding.
  • Financial Gravity Asset Management first reported a position in Medtronic in Q1 2018 and has held it in 15 quarters since.
  • Financial Gravity Asset Management's Medtronic position peaked at $125K in Q3 2021.
  • 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.